Update: Nirsevimab (Beyfortus) – FAQs for Healthcare Professionals
Access Resources
About
This update from the Pediatric Pandemic Network (PPN) describes the new guidelines from the CDC with additional recommendations from the FDA, AAP, and AAFP. There are detailed answers regarding who should receive the vaccine when available, how to prepare for administration, billing, and other common questions healthcare providers may have about Nirsevimab.
Tags
More like this
The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.